Severe hypoglycemia is a life-threatening medical emergency that demands swift, decisive action. For individuals with diabetes, especially those on insulin or certain oral medications, blood glucose can drop to dangerous levels, leading to confusion, unconsciousness, or seizures. In such situations, glucagon kits serve as a critical rescue tool, raising blood sugar by stimulating the liver to release stored glucose. Unlike oral carbohydrates, glucagon can be administered when a person is unable to swallow or is unresponsive. Mastering the proper use of these kits is essential for caregivers, family members, teachers, and anyone who regularly interacts with a person at risk. This comprehensive guide walks through everything you need to know to use glucagon kits effectively, from recognizing an emergency to taking post-administration steps for recovery.

Understanding Glucagon and Its Importance

Glucagon is a naturally occurring hormone produced by the pancreas that counteracts insulin by raising blood glucose levels. In a severe hypoglycemic episode, the body’s own glucagon response may be insufficient, particularly in people with long-standing diabetes. Synthetic glucagon, available in emergency kits, mimics this action. The American Diabetes Association emphasizes that prompt glucagon administration can prevent brain damage, coma, or death during a severe low blood sugar event. Understanding the physiological role of glucagon helps underscore why these kits are indispensable: they bypass the digestive system entirely, enabling rapid absorption into the bloodstream through intramuscular injection. Without intervention, prolonged severe hypoglycemia can lead to irreversible neurological compromise, making familiarity with glucagon kits a non-negotiable aspect of diabetes management.

There are multiple formulations of glucagon available, including injectable kits with powder and diluent, ready-to-use auto-injectors, and nasal powders. While the basic principle remains the same—delivering glucagon to quickly elevate blood sugar—the administration method varies. Injectable kits require manual mixing and injection, whereas auto-injectors and nasal powders offer simpler, more intuitive designs, reducing the chance of error in high-stress scenarios. The American Diabetes Association recommends that all individuals with diabetes who are at significant risk of severe hypoglycemia (including those with a history of unawareness or recent episodes) have a glucagon kit readily accessible and that their close contacts receive hands-on training on its use.

Recognizing Severe Hypoglycemia

Timely recognition of severe hypoglycemia is the first critical step in effective glucagon administration. Mild hypoglycemia (blood glucose typically below 70 mg/dL) presents with symptoms such as shakiness, sweating, rapid heartbeat, hunger, and anxiety, and can usually be treated with oral glucose like juice or glucose tablets. Severe hypoglycemia, however, involves cognitive impairment or physical incapacitation that prevents self-treatment. Symptoms include confusion, slurred speech, inability to concentrate, blurred vision, unusual behavior, drowsiness, seizures, or loss of consciousness. In some cases, especially with long-standing diabetes or autonomic neuropathy, the person may not experience warning signs (hypoglycemia unawareness). It is vital to err on the side of caution: if a person with known risk factors becomes unresponsive or cannot swallow, assume severe hypoglycemia and administer glucagon immediately—even without a blood glucose reading. The U.S. Centers for Disease Control and Prevention (CDC) notes that delays in treatment increase the risk of serious complications, so rapid action is paramount.

Differentiating severe hypoglycemia from other medical crises (such as stroke, seizure disorders, or intoxication) is important but should not delay treatment. If there is any indication of low blood sugar in a person with diabetes, glucagon is safe to administer, as its effects are temporary and reversible. Erring on the side of administration is far better than withholding a potentially lifesaving medication. Additionally, teaching all regular contacts—family members, coworkers, school nurses, and dormitory roommates—how to recognize these signs forms a vital safety net. They should be trained to not attempt to force food or liquid into an unresponsive person, as this can cause choking or aspiration. Glucagon is the correct, safe alternative.

Step-by-Step Guide to Administering a Glucagon Kit

Proper administration of a glucagon kit requires calm, systematic action. While each brand and formulation (injectable, auto-injector, nasal) has specific instructions, the general steps for injectable kits—the most common type—are outlined below. Auto-injectors and nasal powders simplify some steps but still demand familiarity. Always read the manufacturer’s package insert for brand-specific instructions and practice with trainer devices if available. Do not wait for professional medical help to apply the kit; it is designed for lay use.

Prepare the Kit

First, locate the glucagon kit and ensure it is within its expiration date. Remove all components from the packaging: a vial of glucagon powder, a syringe (or vial) containing sterile diluent, an alcohol swab (if included), and injection instructions. Place the items on a clean, flat surface. If the person is unconscious, you may need to gently restrain them to avoid thrashing, but remain focused on the tasks. If a companion is present, designate one person to call 911 or local emergency services while the other prepares the injection; emergency services should be contacted immediately as glucagon is a temporary measure.

Mix the Solution

Remove the protective cap from the diluent syringe and inject the entire volume of liquid into the vial containing the glucagon powder. The syringe may be pre-filled or require drawing the diluent first. After injecting, keep the syringe in the vial (if it is the same needle) or remove it. Gently swirl or roll the vial between your palms until the powder fully dissolves. Do not shake vigorously, as foaming can degrade glucagon and complicate dosing. The resulting solution should be clear and colorless. If it remains cloudy, contains particles, or if the vial is damaged, do not use—discard it and use an alternative kit.

Select the Injection Site and Technique

The recommended injection site is the outer middle third of the thigh (vastus lateralis muscle), as this muscle is easily accessible and has good blood flow. Other acceptable sites include the deltoid muscle of the upper arm or the buttock (gluteal muscle), but the thigh is preferred for self-use or when the person is lying down. Clean the injection site with an alcohol swab if available, though in an emergency this step is optional—do not delay the injection for disinfection. Using the same syringe you used for mixing (or a separate injection syringe, depending on kit design), draw all the mixed solution into the syringe. Remove any air bubbles by gently tapping and pushing the plunger slightly. With one hand, stabilize the person’s thigh, and with the other, insert the needle at a 90-degree angle directly into the muscle. Inject the entire volume steadily. Withdraw the needle quickly, and apply gentle pressure with a dry gauze or swab. Do not recap the needle; place it in a sharps disposal container if available, or a puncture-resistant container.

Post-Administration Monitoring and Care

After the injection, continue to monitor the person closely. Most individuals will begin to recover within 5 to 15 minutes, showing signs such as groaning, opening eyes, or regaining consciousness. If there is no response after 15 minutes, a second dose of glucagon may be administered if a second kit is available, but only after emergency medical services (EMS) have been consulted—this is rare and typically not recommended for lay caregivers. Once the person is awake and able to swallow safely, offer a fast-acting carbohydrate source (e.g., fruit juice, glucose tablets, regular soda) followed by a larger, longer-lasting carbohydrate and protein snack (such as crackers with cheese or a sandwich) to stabilize blood sugar and prevent recurrence. Even if the person recovers fully, they should be evaluated by a healthcare professional, as the underlying cause of severe hypoglycemia should be addressed, and further treatment may be needed.

Important Tips and Precautions

Effective use of glucagon kits extends beyond the injection itself. Several practical and safety considerations can improve outcomes and reduce risks.

Storage and Expiry Management

Glucagon kits are heat-sensitive and must be stored at controlled room temperature (typically between 20°C and 25°C or 68°F and 77°F). Avoid exposing them to direct sunlight, extreme heat (such as in a car glove box during summer), or freezing temperatures. Check the expiration date printed on the kit monthly. Expired glucagon may lose potency and fail to raise blood glucose adequately. Write the expiration date on a calendar or set a phone reminder. If a kit is nearing expiration, replace it and consider donating the old kit to a certified diabetes education program or pharmacy take-back program. Also, store the kit in a location known to all household members, but out of reach of children (though the packaging is child-resistant).

Training for Caregivers and Family Members

Hands-on training is vital. Many endocrinology clinics, diabetes educators, and local American Diabetes Association chapters offer training sessions using demo kits that contain no needle or active drug. Family members, roommates, coworkers, and school staff should practice the steps at least annually. Training should include recognizing symptoms of severe hypoglycemia, retrieving the kit, mixing and injecting (with a trainer), and calling for help. Keep written instructions or a quick-reference card in the kit case. For individuals who live alone or frequently travel, consider alerting neighbors or hotel staff about the condition and kit location.

Potential Side Effects and What to Expect

Glucagon is generally safe, but it can cause side effects such as nausea, vomiting, headache, or weakness. Vomiting is common after recovery, so after the person regains consciousness, help them sit up or roll onto their side to prevent aspiration. The injection site may be sore. Rarely, allergic reactions (rash, difficulty breathing) occur, but these are uncommon. Because glucagon mobilizes stored glucose from the liver, people with conditions that deplete liver glycogen (such as severe malnutrition, starvation, or some metabolic disorders) may have a diminished response. In such cases, repeat dosing may be ineffective, and immediate advanced medical care is critical.

When Not to Use Glucagon

Glucagon is not recommended for individuals with known pheochromocytoma (a rare adrenal tumor) because it can cause severe hypertension. It should be used with caution in those with cardiac disease or a history of insulinoma. However, in an emergency, when a person is unconscious or seizing from presumed severe hypoglycemia, the benefits overwhelmingly outweigh the risks. If there is any doubt about the cause of unconsciousness (e.g., stroke or intoxication), administering glucagon is still advised because it will not cause harm and may be lifesaving if hypoglycemia is present.

Who Should Keep a Glucagon Kit?

Glucagon kits are recommended for all individuals with type 1 diabetes, as well as selected individuals with type 2 diabetes who are taking insulin or sulfonylureas and have a history of severe hypoglycemia, hypoglycemia unawareness, or other high-risk factors. The Endocrine Society and the American Diabetes Association both recommend that any person who has had one severe hypoglycemic episode should be prescribed a glucagon kit and given training on its use. This includes children and adolescents with diabetes, who should have kits at school, day care, and after-school activities. Additionally, for individuals who engage in intensive physical activity, frequently skip meals, or consume alcohol—all of which can increase hypoglycemia risk—having a kit readily available adds a layer of safety. Caregivers of older adults with diabetes who rely on insulin or sulfonylureas should also keep a kit on hand, as age-related kidney decline or polypharmacy can increase vulnerability.

Even if a person has never experienced severe hypoglycemia, proactive planning is wise. Consult with a healthcare provider to determine if a glucagon prescription is appropriate based on the individual’s medication regimen, lifestyle, and medical history. Some insurance plans cover glucagon kits with a copay, and patient assistance programs are available for those with financial constraints. Organizations like the American Diabetes Association provide resources for obtaining and using glucagon.

Conclusion

Severe hypoglycemia remains one of the most dangerous acute complications of diabetes, but with proper knowledge and preparation, it can be managed effectively. Glucagon kits are a simple, powerful intervention that can prevent catastrophic outcomes when used correctly. Key takeaways include the necessity of early recognition, the importance of training all potential responders, the step-by-step administration process, and ongoing vigilance regarding expiration dates and storage. Every caregiver should understand that glucagon is a bridging therapy—immediate activation of emergency medical services is essential, even if the person appears to recover fully after the injection. By integrating these principles into a comprehensive diabetes safety plan, families and communities can reduce fear and ensure that treatment is delivered swiftly and confidently when it matters most. For further reading, consult the CDC Diabetes page or review the Endocrine Society’s clinical practice guidelines on hypoglycemia management.